Related Experiment Video
Updated: Jun 19, 2026

17:16
Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
Published on: December 9, 2010
Biomarkers in Clinical Trials--SMi Conference. 23-24 September 2009, London, UK
1Thomson Reuters, Hatton Garden, London, EC1N 8JS, UK. glenda.walker@thomsonreuters.com
Abstract:
The Biomarkers in Clinical Trials conference, held in London, included topics covering new developments in the field of biomarkers. This conference report highlights selected presentations on the definition of biomarkers, the use of biomarkers to support decisions in drug development and to improve treatment outcomes, and the aims of the Biomarkers Consortium. A case study of the investigational drug selumetinib (AstraZeneca plc) is also discussed.

